Aller au contenu principal
Accès ouvert déclaré 2026 preprint

Kidney function and kidney failure prediction in a large multiethnic population

0Citations signalées, ce qui n’est pas une note de qualité
9Institutions déclarées
2Pays d’affiliation déclarés

Rattachement africain : il, us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Background: Patients with chronic kidney disease (CKD) experience worsening kidney function and develop subsequent kidney failure at different rates. Accurate estimates of a patient's current and future kidney function are needed for optimal clinical decision-making. Methods: To compare current and previously recommended equations for estimating kidney function and risk of kidney failure across a large multiethnic population, we conducted a retrospective multicenter cohort study of primary care, acute care, and hospital settings. Our study population comprised 1,909,042 adults with at least one recorded serum creatinine measurement during 2012-2014, with follow-up until January 2025. Our primary outcomes were the area under the receiver operating characteristic curve and prevalence of CKD by stage across regions of origin. Findings: GFR estimates from the two race-stratified equations (2006 MDRD and 2009 CKD-EPI) were similarly calibrated. GFR estimates from the two race-neutral equations diverged, with 2021 EKFC producing lower GFR estimates and 2021 CKD-EPI producing higher GFR estimates compared to prior equations. The oldest equation, 2006 MDRD, was the most discriminative of kidney failure within 5 years while the newer European equation, 2021 EKFC, was the least discriminative, with AUROCs of 0.862 (95% CI, 0.855-0.869) and 0.846 (95% CI, 0.838-0.853), respectively. The age-adjusted prevalence of CKD varied by the choice of eGFR equation (ranging from 8.5% for 2021 CKD-EPI to 10.8% for EKFC) and across regions of birth (ranging from 8.9% for East Sub-Saharan Africa to 15.3% for South Asia). Interpretation: Using 10 years of follow-up for nearly 2 million individuals, our study demonstrates how newly developed US and European equations diverge from previously recommended equations with broad clinical and epidemiological implications.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

Aucun DOI disponible pour le contrôle Crossref.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Chronic Kidney Disease and DiabetesAcute Kidney Injury ResearchDialysis and Renal Disease Management

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.